Home > Insider Trading > Filing (0001035267-24-000257)

Filing Details

Accession Number:: 0001035267-24-000257
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-10-31 12:22:44
Reporting Period:: 2024-10-30

Accepted Time:: 2024-10-31 12:22:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1035267	Intuitive Surgical Inc	ISRG	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	770416458

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1280628	S Gary Guthart	1020 Kifer Road Sunnyvale CA 94086	Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-10-30	25,200	$59.23	42,370	No	4	M	Direct
Common Stock	Disposition	2024-10-30	18,151	$511.63	24,219	No	4	S	Direct
Common Stock	Disposition	2024-10-30	3,720	$510.52	19,920	No	4	S	Indirect	Trust FBO Daughter
Common Stock	Disposition	2024-10-30	3,720	$510.75	19,920	No	4	S	Indirect	Trust FBO Son

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Indirect	Trust FBO Daughter
No	4	S	Indirect	Trust FBO Son

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2024-10-30	25,200	$0.00	25,200	$59.23

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2025-08-17	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,191,144	Indirect	by Trust

Footnotes

The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 30, 2025.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $508.66 to $516.87 as follows: 1,504 shares sold at $508.66 to $509.50; 8,289 shares sold at $509.67 to $510.63; 3,083 shares sold at $510.68 to $511.54; 775 shares sold at $511.91to $512.30; 599 shares sold at $513.14 to $514.09; 1,728 shares sold at $514.28 to $515.26; 274 shares sold at $515.38 to $515.99; and 1,899 shares sold at $516.56 to $516.87. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $508.51 to $516.31 as follows: 415 shares sold at $508.51 to $509.24; 1,993 shares sold at $509.53 to $510.49; 693 shares sold at $510.54 to $510.93; 320 shares sold at $511.57 to $512.22; 127 shares sold at $512.61 to $512.74; 100 shares sold at $514.47; and 72 shares sold at $516.31. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $508.52 to $516.67 as follows: 388 shares sold at $508.52 to $509.06; 1,698 shares sold at $509.53 to $510.49; 1,155 shares sold at $510.63 to $511.54; 215 shares sold at $511.84 to $512.76; and 264 shares sold at $516.31 to $516.67. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.